Follow The Filings

COCH Envoy Medical

Envoy Medical earnings company data as of 4:47 AM ET 10/24

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 9 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by COCH's executives, directors and 10% owners in the last 12 months, from their Form 4s

All COCH insider trades
  • $8.2M bought by 6 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Glen A Taylor 10% owner
    Buy
    $7.5M 18.8M shares at $0.4000 +635% to stake
    Traded Feb 12 Filed Feb 17
    ↗
  2. Mona Chetan Patel Director
    Buy
    $125K 312,500 shares at $0.4000 +1563% to stake
    Traded Feb 12 Filed Feb 17
    ↗
  3. Robert Potashnick CFO
    Buy
    $85K 212,500 shares at $0.4000 New stake
    Traded Feb 12 Filed Feb 17
    ↗
  4. Susan Kantor Director
    Buy
    $38K 96,150 shares at $0.4000 +123% to stake
    Traded Feb 12 Filed Feb 17
    ↗
  5. Charles Brynelsen Director
    Buy
    $400K 1,000,000 shares at $0.4000 +2000% to stake
    Traded Feb 12 Filed Feb 17
    ↗
  6. Brent T. Lucas CEO
    Buy
    $25K 62,500 shares at $0.4000 +27% to stake
    Traded Feb 12 Filed Feb 17
    ↗

Also filed in the last 12 months, not counted as buying or selling: 2 stock grants.

SEC filings

Recent issuer filings from EDGAR, 25 shown.

Filed Form Detail Links
8-K 5.07,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
DEFA14A DEFINITIVE ADDITIONAL MATERIALS Filing Doc
DEF 14A PROXY STATEMENT Filing Doc
8-K 5.02,9.01 Filing Doc
10-Q QUARTERLY REPORT Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 1.02,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 3.01 Filing Doc
8-K 5.02,5.07,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q QUARTERLY REPORT Filing Doc
8-K 5.02,9.01 Filing Doc
10-K/A AMENDMENT NO. 1 TO FORM 10-K Filing Doc
DEF 14A PROXY STATEMENT Filing Doc
DEFA14A DEFINITIVE ADDITIONAL MATERIALS Filing Doc
8-K 4.01,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-K ANNUAL REPORT Filing Doc
8-K 3.01,8.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 7 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.